David M. Bolduc

633 total citations
13 papers, 371 citations indexed

About

David M. Bolduc is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David M. Bolduc has authored 13 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in David M. Bolduc's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Biochemical and Molecular Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). David M. Bolduc is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Biochemical and Molecular Research (4 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). David M. Bolduc collaborates with scholars based in United States. David M. Bolduc's co-authors include Philip A. Cole, Zan Chen, L. Mario Amzel, Sandra B. Gabelli, Daniel R. Dempsey, Stefani N. Thomas, Peter N. Devreotes, Becky Tu‐Sekine, Daniel M. Raben and Meghdad Rahdar and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

David M. Bolduc

13 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David M. Bolduc United States 10 324 78 50 46 29 13 371
Sreedhar Venkannagari United States 6 341 1.1× 97 1.2× 68 1.4× 36 0.8× 37 1.3× 8 415
Daniel A Luedtke United States 7 332 1.0× 105 1.3× 32 0.6× 37 0.8× 17 0.6× 10 436
Hélène Malka-Mahieu France 6 387 1.2× 136 1.7× 24 0.5× 51 1.1× 29 1.0× 10 456
Stela Álvarez-Fernández Spain 8 216 0.7× 83 1.1× 49 1.0× 76 1.7× 34 1.2× 11 363
Cynthia K. Hahn United States 6 250 0.8× 53 0.7× 82 1.6× 52 1.1× 24 0.8× 11 368
Charina Ortega United States 3 220 0.7× 71 0.9× 29 0.6× 31 0.7× 23 0.8× 4 294
Robert H. Sinnamon United States 6 510 1.6× 141 1.8× 57 1.1× 36 0.8× 47 1.6× 7 566
Chu Myong Seong South Korea 12 360 1.1× 133 1.7× 36 0.7× 51 1.1× 38 1.3× 30 511
Soraya Wuillème‐Toumi France 5 467 1.4× 151 1.9× 37 0.7× 48 1.0× 41 1.4× 6 553
Mike Berger United States 2 284 0.9× 53 0.7× 29 0.6× 40 0.9× 12 0.4× 3 344

Countries citing papers authored by David M. Bolduc

Since Specialization
Citations

This map shows the geographic impact of David M. Bolduc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Bolduc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Bolduc more than expected).

Fields of papers citing papers by David M. Bolduc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Bolduc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Bolduc. The network helps show where David M. Bolduc may publish in the future.

Co-authorship network of co-authors of David M. Bolduc

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Bolduc. A scholar is included among the top collaborators of David M. Bolduc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Bolduc. David M. Bolduc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Parker, Mackenzie J., Hyelee Lee, Shihua Yao, et al.. (2023). Identification of 2-Sulfonyl/Sulfonamide Pyrimidines as Covalent Inhibitors of WRN Using a Multiplexed High-Throughput Screening Assay. Biochemistry. 62(14). 2147–2160. 16 indexed citations
2.
Yao, Shihua, Tuong-Vi Nguyen, Alan Rolfe, et al.. (2021). Abstract 2334: Discovery of selective inhibitors of carbamoyl phosphate synthetase I (CPS1) to modulate cancer relevant metabolic pathways. Cancer Research. 81(13_Supplement). 2334–2334. 1 indexed citations
3.
Yao, Shihua, Tuong-Vi Nguyen, Alan Rolfe, et al.. (2020). Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket. Cell chemical biology. 27(3). 259–268.e5. 27 indexed citations
4.
Rolfe, Alan, Shihua Yao, Kiyoyuki Omoto, et al.. (2020). Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1. ACS Medicinal Chemistry Letters. 11(6). 1305–1309. 8 indexed citations
5.
Cook, Andrew S., Kiyoyuki Omoto, Jiyuan Ke, et al.. (2020). Discovery of Aminopyrazole Derivatives as Potent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR2 and 3. ACS Medicinal Chemistry Letters. 12(1). 93–98. 16 indexed citations
6.
Nguyen, Tuong-Vi, Shihua Yao, Yahong Wang, et al.. (2019). The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity. Journal of Biological Chemistry. 294(45). 16966–16977. 22 indexed citations
7.
Chen, Zan, Daniel R. Dempsey, Stefani N. Thomas, et al.. (2016). Molecular Features of Phosphatase and Tensin Homolog (PTEN) Regulation by C-terminal Phosphorylation. Journal of Biological Chemistry. 291(27). 14160–14169. 41 indexed citations
8.
Chu, Nam, Zan Chen, David M. Bolduc, et al.. (2016). Enzyme-catalyzed expressed protein ligation. Nature Methods. 13(11). 925–927. 45 indexed citations
9.
Chen, Zan, Stefani N. Thomas, David M. Bolduc, et al.. (2016). Enzymatic Analysis of PTEN Ubiquitylation by WWP2 and NEDD4-1 E3 Ligases. Biochemistry. 55(26). 3658–3666. 36 indexed citations
10.
Chu, Nam, et al.. (2016). Enzyme Catalyzed Expressed Protein Ligation. The FASEB Journal. 30(S1). 1 indexed citations
11.
Miller, Michelle S., Oleg Schmidt‐Kittler, David M. Bolduc, et al.. (2014). Structural basis of nSH2 regulation and lipid binding in PI3Kα. Oncotarget. 5(14). 5198–5208. 60 indexed citations
12.
Holbert, Marc A., Jay H. Kalin, Young‐Hoon Ahn, et al.. (2014). An Fc Domain Protein–Small Molecule Conjugate as an Enhanced Immunomodulator. Journal of the American Chemical Society. 136(9). 3370–3373. 16 indexed citations
13.
Bolduc, David M., Meghdad Rahdar, Becky Tu‐Sekine, et al.. (2013). Phosphorylation-mediated PTEN conformational closure and deactivation revealed with protein semisynthesis. eLife. 2. e00691–e00691. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026